INTS vs TSN
Intensity Therapeutics, Inc. Common stock (INTS) versus Tyson Foods Inc (TSN) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Tyson Foods Inc (TSN) is a farm products company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported TSN revenue for 2025-09-27 was $54.44B. Net income was $507.0M. Revenue was up 2.1% from 2024-09-28 to 2025-09-27. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
INTS currently screens at market cap $7.7M. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
Not investment advice. Open the INTS and TSN stock pages for the full models.
Not investment advice.